For 40 years, Apotex has been a trusted name in the Canadian pharmaceutical community, providing patients around the globe with increased access to quality, affordable medicines. Since our founding, we have been dedicated to maintaining sustainable, state-of-the-art processes – processes that ensure our products meet the highest quality and safety standards in all markets. Through our unwavering commitment to excellence and innovation, we help communities across the world live longer, healthier lives.

news Apotex Canada Press Releases RSS
find us on Apotex on YouTube
March 31, 2016
Launch of Key Biosimilar Medicine To Help Save Healthcare Budgets
Apobiologix®, a Division of Apotex Inc., today launched Grastofil®, its first subsequent entry biologic (SEB) approved in Canada. ...
> more news